Research from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has identified an enzyme’s key role in the production of blood cells — a finding that could lead to new clinical strategies for inhibiting cancer.
“Normal blood-forming cells respond to signals from the environment, such as stress, inflammation or infection,” said Stephen D. Nimer, M.D., Director of Sylvester, and professor of medicine, biochemistry and molecular biology. “However, that signaling pathway is subverted in cancer cells, which continue to grow, endangering vital organs and systems.”
Up Close with Dr. Guillermo “Willy” Prado: ‘The right guidance can help change communities and people’s choices’
Guillermo “Willy” Prado, Ph.D., M.S., chats with Medical Communications to discuss his vision for preventive health mechanisms, his goal to train future preventive health scientists in the Miller School of Medicine’s new public health doctoral degree program, and his recent work to expand Familias Unidas in Ecuador, Chile and Colombia.
Ernesto Bernal-Mizrachi, M.D., has been named Chief of the Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine and Deputy Director of Beta Cell Biology and Signal Transduction at the Diabetes Research Institute at the University of Miami Miller School of Medicine.
A genetics researcher at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has identified a protein that drives the development of embryonic stem cells into functional cardiac cells — a finding that could lead to a better understanding of heart disease.
Sylvester Comprehensive Cancer Center is leading a new research partnership with South Florida Fire Rescue Departments to understand why firefighters face a high risk of cancer and find ways to improve their health and safety.
The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced that the first patient in its clinical trial to test for the first time a novel transplant technique for insulin-producing cells has been successfully completed.